Menu
GeneBe

ITGAM

integrin subunit alpha M, the group of CD molecules|Integrin alpha subunits|Complement system regulators and receptors

Basic information

Region (hg38): 16:31259966-31332892

Previous symbols: [ "CR3A", "CD11B" ]

Links

ENSG00000169896NCBI:3684OMIM:120980HGNC:6149Uniprot:P11215AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ITGAM gene.

  • not provided (609 variants)
  • Inborn genetic diseases (39 variants)
  • ITGAM-related condition (3 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ITGAM gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
124
clinvar
9
clinvar
133
missense
289
clinvar
17
clinvar
10
clinvar
316
nonsense
9
clinvar
2
clinvar
11
start loss
0
frameshift
7
clinvar
7
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
6
clinvar
6
splice region
18
24
1
43
non coding
12
clinvar
89
clinvar
9
clinvar
110
Total 0 0 325 232 28

Variants in ITGAM

This is a list of pathogenic ClinVar variants found in the ITGAM region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-31260068-G-T Uncertain significance (Jan 06, 2024)2707877
16-31260071-C-T Uncertain significance (Oct 26, 2023)2168374
16-31260072-T-G Uncertain significance (Aug 16, 2023)2052199
16-31260078-T-C Uncertain significance (Nov 23, 2021)1490534
16-31260079-C-G Likely benign (Nov 11, 2023)2695140
16-31260097-A-C Uncertain significance (Nov 11, 2023)1434930
16-31260099-G-A Likely benign (Nov 08, 2022)1657194
16-31260105-G-C Likely benign (Apr 14, 2021)1550918
16-31260106-G-GCAC Likely benign (Sep 27, 2022)1670129
16-31260109-T-A Likely benign (Jan 26, 2024)2802165
16-31261679-A-C Likely benign (Sep 28, 2022)1538088
16-31261686-C-T Likely benign (Jun 05, 2023)2877900
16-31261718-T-C Likely benign (Jun 26, 2023)2784047
16-31261721-G-A Uncertain significance (Jun 15, 2022)2006976
16-31261722-A-G Uncertain significance (Dec 24, 2023)1378132
16-31261725-C-T Uncertain significance (Oct 22, 2023)2192967
16-31261732-C-T Likely benign (Oct 13, 2023)1898123
16-31261753-C-T Likely benign (Dec 30, 2023)1968348
16-31261759-G-A Likely benign (Feb 10, 2022)1655598
16-31261765-C-T Likely benign (Nov 27, 2023)1638909
16-31261766-G-A Uncertain significance (Jul 11, 2022)1524198
16-31261774-C-T Likely benign (Jan 24, 2023)1652756
16-31261775-G-A Uncertain significance (Nov 24, 2023)1412109
16-31261785-T-A Uncertain significance (Dec 25, 2023)1354817
16-31261795-C-A Likely benign (Oct 27, 2022)2809948

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ITGAMprotein_codingprotein_codingENST00000544665 3072903
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.31e-111.0012540601521255580.000605
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.425826870.8470.00004107488
Missense in Polyphen207273.920.755683135
Synonymous1.042622840.9220.00001792287
Loss of Function3.872860.50.4630.00000305677

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0006420.000610
Ashkenazi Jewish0.004270.00408
East Asian0.0003980.000381
Finnish0.000.00
European (Non-Finnish)0.0006350.000625
Middle Eastern0.0003980.000381
South Asian0.0005660.000555
Other0.0005010.000491

dbNSFP

Source: dbNSFP

Function
FUNCTION: Integrin ITGAM/ITGB2 is implicated in various adhesive interactions of monocytes, macrophages and granulocytes as well as in mediating the uptake of complement-coated particles. It is identical with CR-3, the receptor for the iC3b fragment of the third complement component. It probably recognizes the R-G-D peptide in C3b. Integrin ITGAM/ITGB2 is also a receptor for fibrinogen, factor X and ICAM1. It recognizes P1 and P2 peptides of fibrinogen gamma chain. Regulates neutrophil migration (PubMed:28807980). In association with beta subunit ITGB2/CD18, required for CD177-PRTN3-mediated activation of TNF primed neutrophils (PubMed:21193407). May regulate phagocytosis-induced apoptosis in extravasated neutrophils (By similarity). May play a role in mast cell development (By similarity). {ECO:0000250|UniProtKB:P05555, ECO:0000269|PubMed:21193407, ECO:0000269|PubMed:28807980, ECO:0000305}.;
Disease
DISEASE: Systemic lupus erythematosus 6 (SLEB6) [MIM:609939]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. {ECO:0000269|PubMed:18204446, ECO:0000269|PubMed:18204448}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Pathway
Complement and coagulation cascades - Homo sapiens (human);Cell adhesion molecules (CAMs) - Homo sapiens (human);Pertussis - Homo sapiens (human);Legionellosis - Homo sapiens (human);Acute myeloid leukemia - Homo sapiens (human);Phagosome - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Staphylococcus aureus infection - Homo sapiens (human);Tuberculosis - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Leishmaniasis - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Integrin-mediated Cell Adhesion;Vitamin D Receptor Pathway;Focal Adhesion;Microglia Pathogen Phagocytosis Pathway;TYROBP Causal Network;Interleukin-4 and 13 signaling;Fibrin Complement Receptor 3 Signaling Pathway;Neutrophil degranulation;Integrin cell surface interactions;Toll-Like Receptors Cascades;Extracellular matrix organization;Innate Immune System;Immune System;Integrin;Cell surface interactions at the vascular wall;Hemostasis;Toll Like Receptor 4 (TLR4) Cascade;amb2 Integrin signaling;Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling;Beta2 integrin cell surface interactions (Consensus)

Intolerance Scores

loftool
0.543
rvis_EVS
-0.59
rvis_percentile_EVS
18.28

Haploinsufficiency Scores

pHI
0.102
hipred
N
hipred_score
0.474
ghis
0.548

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.562

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Itgam
Phenotype
cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype;

Gene ontology

Biological process
microglial cell activation;phagocytosis, engulfment;cell adhesion;integrin-mediated signaling pathway;ectodermal cell differentiation;cytokine-mediated signaling pathway;extracellular matrix organization;positive regulation of superoxide anion generation;toll-like receptor 4 signaling pathway;neutrophil degranulation;positive regulation of neutrophil degranulation;innate immune response;negative regulation of dopamine metabolic process;leukocyte migration;positive regulation of phagocytosis, engulfment;positive regulation of protein targeting to membrane;amyloid-beta clearance;cell-cell adhesion via plasma-membrane adhesion molecules;complement-mediated synapse pruning;vertebrate eye-specific patterning;positive regulation of neuron death;positive regulation of microglial cell activation;cell surface receptor signaling pathway involved in cell-cell signaling;positive regulation of prostaglandin-E synthase activity
Cellular component
extracellular space;plasma membrane;integrin complex;external side of plasma membrane;cell surface;integrin alphaM-beta2 complex;specific granule membrane;plasma membrane raft;extracellular exosome;tertiary granule membrane
Molecular function
amyloid-beta binding;complement component C3b binding;protein binding;heat shock protein binding;metal ion binding;protein heterodimerization activity